KC Star Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Biogen Idec, Inc. (NQ: BIIB)
232.56 USD  +7.38 (+3.28%)
Streaming Delayed Price  /  Updated: 3:01 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 906,265
Open 226.17
Bid (Size) 232.48 (100)
Ask (Size) 232.57 (300)
Prev. Close 225.18
Today's Range 226.00 - 234.20
52wk Range 126.39 - 231.99
Shares Outstanding 237,374,815
Dividend Yield N/A
Top News
More News
49.9% Return Seen to Date on SmarTrend Biogen Idec Call (BIIB)
Today 12:06 EDT
from Comtex SmarTrend® News Briefs
Biogen Idec Submits BLA to FDA for Approval of PLEGRIDY for Multiple Sclerosis
Today 5:55 EDT
Today Biogen Idec (NASDAQ: BIIB ) announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY™ (peginterferon Read More
category Contracts , Management , Benzinga , and 5 more.
from Latest Articles from Benzinga.com

More News
Read More
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Today 5:00 EDT
from Business Wire News Releases
Biogen Idec presenta solicitud ante la FDA para aprobación de PLEGRIDY™ (Peginterferón Beta-1a) sobre esclerosis múltiple
Today 4:30 EDT
from Business Wire Spanish
Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis
Today 4:30 EDT
from Business Wire News Releases
Biogen's (BIIB) BG-12 Data Not Inflated
May 20, 2013
from StreetInsider.com News Articles
Leerink Swann Highlights Big Gains in Prescriptions for Biogen's MS Treatment
May 20, 2013
category Benzinga , News , BIIB , and 2 more.
from Latest Articles from Benzinga.com
Biogen (BIIB) Weeks-6 TECFIDERA Scripts Continue to Ramp
May 20, 2013
from StreetInsider.com News Articles
CORRECTED-Data show new Roche leukemia drug may improve on Rituxan
May 16, 2013
category companyNews
from Reuters: Company News
Data shows new Roche leukemia drug may improve on Rituxan
May 15, 2013
category companyNews
from Reuters: Company News
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here